Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of WC2031 Versus Vibramycin for the Treatment of Uncomplicated Urogenital Chlamydia Trachomatis Infection: A Randomized, Double-blind, Double-dummy, Active-controlled, Multicenter Study

NCT01113931 is registered in ClinicalTrials.gov with Warner Chilcott as lead sponsor.

NCT NCT01113931
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01113931 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of WC2031 Versus Vibramycin for the Treatment of Uncomplicated Urogenital Chlamydia Trachomatis Infection: A Randomized, Double-blind, Double-dummy, Active-controlled, Multicenter Study
Lead sponsor
Warner Chilcott
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2010
Completion date
October 31, 2010
Enrollment
495 (actual)
Sites
43

Conditions

As the registry lists them; a condition with its own page is linked.

urogential chlamydia trachomatis infection